| pubmed-article:12742841 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12742841 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12742841 | lifeskim:mentions | umls-concept:C0000768 | lld:lifeskim |
| pubmed-article:12742841 | lifeskim:mentions | umls-concept:C0042826 | lld:lifeskim |
| pubmed-article:12742841 | lifeskim:mentions | umls-concept:C0028840 | lld:lifeskim |
| pubmed-article:12742841 | lifeskim:mentions | umls-concept:C0008902 | lld:lifeskim |
| pubmed-article:12742841 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:12742841 | pubmed:dateCreated | 2003-5-13 | lld:pubmed |
| pubmed-article:12742841 | pubmed:abstractText | (1) To develop a classification system for visual field (VF) abnormalities, (2) to determine interreader and test-retest agreement, and (3) to determine the frequency of various VF defects in the Ocular Hypertension Treatment Study. | lld:pubmed |
| pubmed-article:12742841 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12742841 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12742841 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12742841 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12742841 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12742841 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:12742841 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12742841 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12742841 | pubmed:month | May | lld:pubmed |
| pubmed-article:12742841 | pubmed:issn | 0003-9950 | lld:pubmed |
| pubmed-article:12742841 | pubmed:author | pubmed-author:KassMichael... | lld:pubmed |
| pubmed-article:12742841 | pubmed:author | pubmed-author:GordonMae OMO | lld:pubmed |
| pubmed-article:12742841 | pubmed:author | pubmed-author:JohnsonChris... | lld:pubmed |
| pubmed-article:12742841 | pubmed:author | pubmed-author:KeltnerJohn... | lld:pubmed |
| pubmed-article:12742841 | pubmed:author | pubmed-author:CelloKimberly... | lld:pubmed |
| pubmed-article:12742841 | pubmed:author | pubmed-author:EdwardsMary... | lld:pubmed |
| pubmed-article:12742841 | pubmed:author | pubmed-author:BandermannSha... | lld:pubmed |
| pubmed-article:12742841 | pubmed:author | pubmed-author:Ocular... | lld:pubmed |
| pubmed-article:12742841 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12742841 | pubmed:volume | 121 | lld:pubmed |
| pubmed-article:12742841 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12742841 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12742841 | pubmed:pagination | 643-50 | lld:pubmed |
| pubmed-article:12742841 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:12742841 | pubmed:meshHeading | pubmed-meshheading:12742841... | lld:pubmed |
| pubmed-article:12742841 | pubmed:meshHeading | pubmed-meshheading:12742841... | lld:pubmed |
| pubmed-article:12742841 | pubmed:meshHeading | pubmed-meshheading:12742841... | lld:pubmed |
| pubmed-article:12742841 | pubmed:meshHeading | pubmed-meshheading:12742841... | lld:pubmed |
| pubmed-article:12742841 | pubmed:meshHeading | pubmed-meshheading:12742841... | lld:pubmed |
| pubmed-article:12742841 | pubmed:meshHeading | pubmed-meshheading:12742841... | lld:pubmed |
| pubmed-article:12742841 | pubmed:meshHeading | pubmed-meshheading:12742841... | lld:pubmed |
| pubmed-article:12742841 | pubmed:meshHeading | pubmed-meshheading:12742841... | lld:pubmed |
| pubmed-article:12742841 | pubmed:meshHeading | pubmed-meshheading:12742841... | lld:pubmed |
| pubmed-article:12742841 | pubmed:meshHeading | pubmed-meshheading:12742841... | lld:pubmed |
| pubmed-article:12742841 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12742841 | pubmed:articleTitle | Classification of visual field abnormalities in the ocular hypertension treatment study. | lld:pubmed |
| pubmed-article:12742841 | pubmed:affiliation | Visual Field Reading Center, Department of Ophthalmology, University of California-Davis, Sacramento, 95817, USA. jlkeltner@ucdavis.edu | lld:pubmed |
| pubmed-article:12742841 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12742841 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12742841 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:12742841 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:12742841 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:12742841 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:12742841 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12742841 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12742841 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12742841 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12742841 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12742841 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12742841 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12742841 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12742841 | lld:pubmed |
